Max J. Kääb

Max J. Kääb

Auto-generated profile, based on publicly available information

Max J. Kääb

Sporthopaedicum Straubing, Straubing, Germany

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
AWAndreas Weiler
Andreas Weiler
ASArno Schmeling
Arno Schmeling
ISIvonne Stöhr
Ivonne Stöhr
MKMax J. Kääb
Max J. Kääb
MWMichael Wagner
Michael Wagner
Background: There is a low level of evidence about clinical results after anterior cruciate ligament (ACL) revision reconstruction using autologous hamstring tendon grafts. Hypothesis: Anterior cruciate ligament revision reconstruction improves knee stability but shows inferior results for functional and subjective outcome and knee stability compared with primary reconstruction. Study Design: Cohort study; Level of evidence, 2. Methods: Between October 1997 and July 2005, 166 single-stage or 2-stage revision ACL reconstructions were done using different graft types. One hundred twenty-four cases underwent a single-stage revision reconstruction with autologous hamstring tendon grafts. At the time of data analysis, 67 cases fulfilled the criteria of minimum 2-year follow-up. Five patients were lost to follow-up (follow-up rate, 91%). Four patients (6%) who experienced graft rupture were counted as failures but not subjected to further detailed analysis. Because of loss to follow-up and exclusion criteria (n = 12), 50 patients were included in the study. For a comparative matched-group analysis, patients with a primary hamstring tendon graft ACL reconstruction were selected out of a database with minimum 2 years’ follow-up (N = 284). Patients were followed using the International Knee Documentation Committee (IKDC) and Lysholm scores, KT-1000 arthrometer testing, and additional functional tests. Results: Four of 62 available patients (6.5%) in the revision group experienced graft failure, which was comparable to 16 of 284 (5.6%) in the primary reconstruction group. When the 2 matched groups of 50 patients were further compared, postoperative IKDC results showed no significant differences between groups. The manual maximum KT-1000 arthrometer side-to-side difference was 2.1 ± 1.6 mm for the revision group and 2.2 ± 1.1 mm for the primary reconstruction group. The Lysholm score was significantly better in the primary reconstruction group (P = .014). The incidence of postoperative positive pivot-shift test results was not significantly different. The primary reconstruction group showed significantly less extension deficits. Functional testing revealed significantly better results for the primary reconstruction group for stair climbing, squatting, knee bending, and duck walk. Conclusions: In our patient series, primary ACL reconstruction showed significantly better results in Lysholm score, although the IKDC score and objective knee stability showed no significant difference between the groups. Thus, parameters other than measurable knee stability must be responsible for the inferior results of the revision reconstruction group.

1 April 2022 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Open access
GKGeorges Kohut
Georges Kohut
FRFalk Reuther
Falk Reuther
TJThierry Joudet
Thierry Joudet
MKMax J. Kääb
Max J. Kääb
UIUlrich Irlenbusch
Ulrich Irlenbusch
Scapular notching is a common complication of reverse total shoulder arthroplasty (RTSA). Inverted-bearing RTSA (IB-RTSA) systems, with polyethylene (PE) glenospheres and metal or ceramic humeral liners, reduce notching and PE wear compared with traditional Grammont prosthesis designs. However, whether notching after IB-RTSA influences clinical outcomes or complications remains unknown. Therefore, we evaluated the influence of notching on midterm clinical outcomes and complication rates after IB-RTSA. In our prospective multicenter, observational study, patients underwent IB-RTSA, using a prosthesis system with a PE glenosphere and a metal humeral component. We assessed patients clinically for functional scores, active range of motion, and pain and radiographically for notching. Overall, 270 patients (284 shoulders) were treated with IB-RTSA. Of these, 229 shoulders were available for a mean follow-up of 86.7 months (range, 24.0-133.4 months). We observed notching in 35% of shoulders (28% grade 1; 3% grade 2; and 4% grade 3). IB-RTSA led to a distinct type of notching representing the mechanical indent of the humeral component into the scapular neck without PE-induced osteolysis. Patients with and without notching showed similar clinical outcomes (P ≥ .05), complication rates (P = .23), revision rates (P = .87), and survival of implant components after 10 years (P = .85). Midterm results confirmed our hypothesis that patients with notching had equally good clinical outcomes and low complication rates as patients without notching. Additionally, we found a distinct type of notching without signs of PE-induced osteolysis.

28 January 2021 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Open access
PDF file
MKMax J. Kääb
Max J. Kääb
GKGeorges Kohut
Georges Kohut
UIUlrich Irlenbusch
Ulrich Irlenbusch
TJThierry Joudet
Thierry Joudet
FRFalk Reuther
Falk Reuther
Introduction: Reverse total shoulder arthroplasty (RTSA) is a widely recognized treatment to reduce pain and improve shoulder function for patients in various disease stages of cuff tear arthropathy (CTA). However, it remains unclear whether outcomes after RTSA depend on the preoperative stage of CTA. Therefore, this study evaluated whether the Hamada classification influences midterm clinical outcomes after RTSA. Materials and methods: In this multicenter observational study, patients underwent inverted bearing RTSA for massive rotator cuff tears or CTA. Shoulders were grouped into those with (Hamada grades 4a, 4b, and 5) and those without (Hamada grades 1, 2, and 3) glenohumeral arthritis. Clinical outcomes, including range of motion, Constant score, American Shoulder and Elbow Surgeons score, and visual analog scale for pain and satisfaction, were determined preoperatively and at 24 and > 30 months. All complications were recorded, and survival free from any implant component revision was calculated. Results: Overall, 202 patients (211 shoulders) were treated with RTSA at a mean age of 75.8 ± 6.6 years (range 41.9–91.6 years). Of these, 144 patients (151 shoulders) were available for a mean follow-up of 79.9 ± 24.7 months (range 30.2–132.3 months). No significant between-group differences were found for clinical outcomes at 24 and > 30 months (P > 0.05). Furthermore, the Hamada classification did not correlate with clinical outcomes at 24 (P = 0.98) and > 30 months (P = 0.29). Revision-free implant component survival was similar between groups (P = 0.17). Postoperative complications were found in 11 shoulders, of which 10 required revision. Conclusions: Inverted bearing RTSA was found to be an effective treatment with similarly good midterm clinical outcomes, similar revision rates, and high implant survival rates in every stage of massive rotator cuff tears. Overall, the preoperative Hamada classification did not influence clinical outcomes or complications after RTSA.

22 June 2020 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
JHJoerg Huber
Joerg Huber
UIUlrich Irlenbusch
Ulrich Irlenbusch
MKMax J. Kääb
Max J. Kääb
FRFalk Reuther
Falk Reuther
GKGeorges Kohut
Georges Kohut
AJAndy Judge
Andy Judge
Background: Although shoulder arthroplasty is less common than knee or hip arthroplasty, the number of procedures being performed is increasing rapidly. The treatment effect is a simple method to measure outcome of joint replacement. The method was applied to measure results of total hip/knee arthroplasty but not yet for shoulder arthroplasty.Methods: Included were patients with unilateral cuff arthropathy (Hamada grades > = 2) treated with reversed total shoulder arthroplasty (RSA) in this prospective multicenter study. The patients were assessed with the ASES questionnaire. The treatment effects (TE) was calculated for each patient. TE = score reduction/baseline score. A positive TE means amelioration, TE = 0 unchanged, and a negative TE means worse. The primary aim was to calculate the TE’s for RSA at 6, 12, 24, and 60 months postoperatively. The secondary aim was to analyze the influence of confounders (preoperative Hamada grade, age, gender, dominance, side of the affected shoulder, general co-morbidities measured using ASA grade).Results: Two hundred three patients were included for this analysis of whom 183 patients had a complete 2 year follow up. Two years postoperatively the mean ASES score augmented significant from 20.5 to 78.7 (p < 0.001). The 2 year TE’s ranged from 1 to 0.09. We had no patient with a negative TE. A higher Hamada grade was associated with better TE’s (Hamada grade 4+ vs. 2,p-value 0.042). For age and dominant side there were weak associations where those aged 80+ and dominant side had better TE’s. The patients with higher ASA grade had lower TE’s (ASA grade 4+ vs. 1,p-value 0.013). The mean TE’s were 0.77 at 6-months, 0.81 at 1 year, 0.76 at 2 years and 0.73 at 5 years.Conclusions: The outcome for reverse shoulder arthroplasty can be measured with the treatment effect method; the 2 years TE’s vary from 1 to 0.09. The mean treatment effects change little in the first five postoperative years (from 0.73 to 0.81). The confounders for better TE’s were: higher severity of cuff arthropathy (Hamada grade 3, 4 and 5), less co-morbidities (ASA Grade 1), higher age (80+) and dominant side. Gender did not influence the 2-year TE’s.Trial registration: Comité intercantonal d’éthique (Jura, Fribourg, Neuchâtel), number 01/2008,24.09.2008.

4 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FRFalk Reuther
Falk Reuther
UIUlrich Irlenbusch
Ulrich Irlenbusch
MKMax J. Kääb
Max J. Kääb
GKGeorges Kohut
Georges Kohut
The purpose of this study is to evaluate the mid-term clinical results of an ongoing case series on conversion reverse shoulder arthroplasty (RSA) with a modular prosthesis system. We included 17 elderly patients revised for failed hemiarthroplasty after proximal humeral fracture, of which 13 were converted using a modular reverse shoulder prosthesis. Four could not be converted due to overstuffing. For the conversion RSA, we determined the Constant score, American Shoulder and Elbow Surgeons Shoulder Score, visual analogue scale for pain and satisfaction, and range of motion preoperatively, at one year, and at the last follow-up. All measured clinical outcomes improved significantly at both follow-up time points (p < 0.05). The mean duration of surgery was 118.4 min (range: 80.0 to 140.0 min). We observed complications in three patients; these included one late infection and two aseptic stem loosenings. Modular shoulder arthroplasty is a suitable procedure for conversion RSA in elderly patients. All measured postoperative clinical outcomes improved significantly, the complication rate was acceptable, and no prosthesis-related complications occurred. Conversion RSA, although not feasible in every case, is a viable treatment option in the elderly, which can provide successful mid-term results.

8 April 2025 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Open access
MKMax J. Kääb
Max J. Kääb
FRFalk Reuther
Falk Reuther
TJThierry Joudet
Thierry Joudet
GKGeorges Kohut
Georges Kohut
UIUlrich Irlenbusch
Ulrich Irlenbusch
Inverted-bearing reverse total shoulder arthroplasty (IB-rTSA) prostheses feature a polyethylene glenosphere and a metallic or ceramic humeral liner. Although midterm clinical results are promising, long-term clinical data with IB-rTSA are limited. Therefore, we evaluated the long-term clinical and radiographic outcomes of IB-rTSA in a variety of shoulder pathologies. Additionally, we reported the type and rate of scapular notching and assessed its effect on clinical results. Finally, we recorded implant survival and complication rates. In this prospective, multicenter, observational study, patients with different shoulder pathologies underwent IB-rTSA with the Affinis Inverse prosthesis. We recorded clinical and functional scores, active range of motion, pain, radiolucent lines, and the type and rate of scapular notching. All complications were documented, and prosthesis survival rates were calculated. We included 318 patients (335 shoulders) with IB-rTSA. The final clinical and radiographic analysis involved 175 patients (183 shoulders), examined at a median of 120.7 months (range, 84.1-172.4 months). At final follow-up, clinical and functional scores, active range of motion, and pain improved significantly from preoperative values (P < .001). Additionally, improvements at the final follow-up in clinical scores and pain substantially exceeded the corresponding minimal clinically important difference determined for rTSA. The type of scapular notching was strikingly different from that observed with conventional rTSA prostheses, and no grade 4 scapular notching was seen. We found scapular notching in 63 (35.8%) shoulders, and the presence of scapular notching did not affect long-term clinical outcomes as well as complication and prosthesis survival rates. The overall prosthesis survival for any revision was 95.7% at 14 years. IB-rTSA with the Affinis Inverse prosthesis resulted in excellent long-term clinical scores and radiographic outcomes, low scapular notching rates, and high prosthesis survival rates in patients with a range of shoulder pathologies. Overall, patients undergoing IB-rTSA can expect good and stable long-term clinical outcomes with low complication and revision rates, making it a viable choice for different shoulder pathologies.